Friday 6 November 2026
Export TFX’s income statement to Excel — free account
Teleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +0.15%
- EPS
- +342.0%
- Free cash flow
- +220.1%
- Total debt
- −39.4%
Quarter to September 2026, against a year earlier
151.46
0.69
−0.45%
Follow TFX
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | 6 | 6 | 5 |
+8 more TTM periods Free account |
| 0.00% | (28.87%) | (28.10%) | (24.47%) | ||
| 4.28% | (14.57%) | (14.47%) | (12.90%) | ||
ROIC |
7.46% | 0.51% | 0.73% | 1.37% | |
Return on Tangible Assets |
21.79% | (63.25%) | (62.71%) | (54.08%) | |
Average Days of Receivables |
61.44 | 59.03 | 62.73 | 63.30 | |
Free Cash Flow per Share |
3.44 | 1.22 | 4.03 | 0.03 | |
Free Cash Flow |
142.73 | 53.12 | 178.56 | 1.45 | |
Capital Expenditures |
(55.09) | (76.14) | (89.89) | (95.24) | |
| Other line items | |||||
Cash ROIC |
2.57% | 0.88% | 2.97% | 0.02% | |
Accounts Receivable Turnover |
4.64 | 5.13 | 5.12 | 6.96 | |
Accounts Payable Turnover |
4.88 | 6.75 | 6.66 | 7.65 | |
Inventory Turnover |
1.27 | 1.94 | 1.86 | 2.45 | |
Average Days of Payables |
69.21 | 51.48 | 54.95 | 54.50 | |
Days of Inventory on Hand |
186.21 | 126.44 | 145.72 | 169.28 | |
Tax Rate |
(0.04) | (0.61) | (1.04) | 1.38 | |
Research and Development Expense of Revenue |
7.46% | 8.10% | 7.71% | 7.27% | |
Selling, General and Administrative Expense of Revenue |
35.84% | 38.56% | 37.30% | 36.14% | |
Share Based Compensation of Revenue |
0.95% | 1.14% | 1.21% | 1.29% | |
Interest Coverage |
5.42 | 0.39 | 0.58 | 1.18 | |
Operating CF/Net income |
0.65 | (0.13) | (0.27) | (0.11) | |
Depreciation/Fixed assets |
(0.59) | 0.45 | 0.42 | 0.37 | |
Capex/Depreciation |
0.20 | (0.36) | (0.45) | (0.52) | |
Revenue per Share |
54.37 | 51.75 | 48.05 | 44.66 | |
Operating CF per Share |
4.77 | 2.97 | 6.07 | 2.17 | |
Capex per Share |
(1.33) | (1.75) | (2.03) | (2.13) | |
Capex to Sales |
0.02 | 0.03 | 0.04 | 0.05 |
Columns are period end dates · fundamentals updated 6 Nov 2026